Vaxil Bio Ltd. (VXL.V)
0.16
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Vaxil Bio Shareholders Equity (Quarterly) : 1.194M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.194M |
| March 31, 2026 | 1.258M |
| December 31, 2025 | 1.365M |
| September 30, 2025 | 0.667M |
| June 30, 2025 | 0.691M |
| March 31, 2025 | 0.644M |
| December 31, 2024 | 0.716M |
| September 30, 2024 | 0.738M |
| June 30, 2024 | 0.787M |
| March 31, 2024 | 0.835M |
| December 31, 2023 | 0.891M |
| September 30, 2023 | 0.86M |
| June 30, 2023 | 0.887M |
| March 31, 2023 | 1.011M |
| December 31, 2022 | 1.136M |
| September 30, 2022 | 1.302M |
| June 30, 2022 | 1.434M |
| March 31, 2022 | 1.575M |
| December 31, 2021 | 1.70M |
| September 30, 2021 | 1.944M |
| June 30, 2021 | 2.176M |
| March 31, 2021 | 2.379M |
| December 31, 2020 | 0.804M |
| September 30, 2020 | 0.20M |
| June 30, 2020 | 0.415M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.37M |
| December 31, 2019 | -0.583M |
| September 30, 2019 | -0.118M |
| June 30, 2019 | 0.062M |
| March 31, 2019 | 0.225M |
| December 31, 2018 | 0.435M |
| September 30, 2018 | 0.786M |
| June 30, 2018 | 0.834M |
| March 31, 2018 | 0.929M |
| December 31, 2017 | -0.487M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.288M |
| March 31, 2017 | 0.655M |
| December 31, 2016 | 0.656M |
| September 30, 2016 | 1.20M |
| June 30, 2016 | 1.49M |
| March 31, 2016 | 1.64M |
| December 31, 2015 | -0.217M |
| September 30, 2015 | -0.373M |
| August 31, 2015 | |
| May 31, 2015 | |
| February 28, 2015 | |
| November 30, 2014 | 0.1416M |
| August 31, 2014 | 0.1514M |
| May 31, 2014 | 0.1879M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Kane Biotech, Inc. | -1.418M |
| Quest PharmaTech, Inc. | 26.43M |
| BriaCell Therapeutics Corp. | 32.75M |
| Waverley Pharma, Inc. | -2.725M |
| Goldcoast Resource Corp. | 0.6796M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.224M |
| Total Liabilities (Quarterly) | 0.03M |
| Current Ratio | 17.97 |